More than 170,000 scientists worldwide across pharma, biotech, and academia
-
Pfizer
One of the world's largest pharmaceutical companies developing cutting-edge drugs in immunology, oncology, cardiology, and more.
-
Regeneron
A leading biotechnology company using the power of science to bring new medicines to patients in need.
-
Eisai
Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.
-
Zoetis
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways, delivering medicines, vaccines, and diagnostic products.
-
Ginkgo
Ginkgo Bioworks is designing custom organisms for customers across multiple markets, learning from nature to replace technology with biology.
-
Sorrento
Sorrento Therapeutics is a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possible curable diseases.
-
CytomX
CytomX is a clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer.
-
Bolt Threads
Bolt Threads is bioengineering the next generation of fabrics and garments with their Microsilk and Mylo technologies.
-
Editas
A leading genome editing company dedicated to treating patients with genetically defined diseases.
-
Rubius
Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines.
Case Study
-
Incyte
Investigating the immune-suppressive tumor microenvironment through both small and large molecule approaches that target diverse mechanisms.
-
Xencor
Expanding the therapeutic boundaries of monoclonal antibody drugs with its XmAb antibody engineering platform.
-
Agenus
Using the power of the immune system to develop a broad range of innovative therapeutic antibody and vaccine candidates against cancer.
Case Study
-
New England Biolabs
Recombinant and native enzyme reagents for life science research. Provides solutions supporting genome editing, synthetic biology and next-generation sequencing.
-
Adicet Bio
Universal, off-the-shelf immune cell therapy for treatment of cancer and other diseases
Case Study
-
uniQure
Delivering on the promise of gene therapy, single treatments with potentially curative results.
-
Lung Biotechnology
Lung Biotechnology's mission is to simplify and democratize the treatment of lung disease, using biotechnology to design therapies for PAH and other fatal lung diseases.
-
Mammoth Biosciences
Mammoth Biosciences provides a CRISPR-based platform for disease detection across healthcare, agriculture, and other industries
-
Synlogic
working at the intersection of biology and engineering, pioneering the application of synthetic biology to design living therapeutics programmed to treat disease in new ways
Case Study
-
Genus
Investigating the application of novel gene editing technologies towards bovine genetics.
-
Voyager Therapeutics
Developing life-changing gene therapies with a focus on severe neurological diseases that lack safe and effective treatment options.
-
Zymergen
Unlocking the power of biology to make strain optimization as reliable and predictable as other engineering processes.
Case Study
-
Surrozen Therapeutics
Surrozen is discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.
-
Caribou Biosciences
Advancing new applications for CRISPR-Cas gene editing to help bring the promise this technology holds for patients and consumers to reality.
-
Arcturus Therapeutics
An industry leader in the application of RNA technologies for the treatment of disease and improved quality of life.
Case Study
-
IGM Biosciences
IGM is pioneering the development of the IgM class of antibodies as therapeutic treatments for human disease.
-
Translate Bio
Translate Bio is an mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
-
Diassess
Diassess's product detects the genetic information of disease pathogens using nucleic acid amplification to provide a highly accurate diagnosis.
-
Inhibrx
Enabling fit-for-function biotherapeutics that optimally interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling.
-
Jnana Therapeutics
Jnana is pushing the frontiers of knowledge and technology to decipher the language of cellular metabolite communication and unlock SLC transporters as a therapeutic target class.
-
Tenaya Therapeutics
Tenaya is addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle.
-
Asimov
Asimov strives to enable biotechnologies with global benefit by combining synthetic biology and computer science.
-
Dragonfly Therapeutics
Developing novel first-in-class therapeutics targeted at Natural Killer cells and other cells of the innate immune system.
-
Adimab
A premier human antibody discovery and optimization platform defined by speed, diversity, and quality.
-
Horizon
A leading gene editing company that designs and engineers genetically modified cells for clinical applications.
-
Synpromics
Improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design.
-
Ligand Pharmaceuticals
Ligand has one of the largest and most diverse portfolios in the pharmaceutical industry. Currently approved portfolio drugs include those that treat cancer, osteoporosis, and fungal infections.
-
ABL Bio
ABL Bio is one of the world's leading biotech research companies focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases.
-
Obsidian Therapeutics
Building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients.
-
enGene
enGene has developed a robust non-viral gene-therapy platform to transport DNA sequences across mucosal barriers.
-
Freenome
Making cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science.
-
MiNA Therapeutics
Harnessing the innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’' cells.
-
Antheia
Providing a stable and cost-competitive supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines.
-
Atreca
Atreca focuses on the immune responses of patients to discover and develop novel immunotherapies.
-
Neucyte
NeuCyte is an innovative biotechnology company focused on CNS drug discovery. NeuCyte has developed an in vitro platform for neurotoxicity assessment, disease modeling, and more.
-
Samplix
Samplix is a biotechnology company that has developed a proprietary technology for single molecule sample preparation.
-
Aether
Aether Biomachines is repurposing enzymes to reinvent previously discovered compounds and create novel compounds.
-
Recursion Pharmaceuticals
Discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers.
-
Harpoon Therapeutics
Leveraging a platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases
-
Maverick Therapeutics
Redirected T cell therapeutics designed to deliver potent activity with increased tumor specificity and reduced toxicity.
-
Scenic Biotech
Scenic is pioneering genetic modifies for drug discovery to build a pipeline of breakthrough products.
-
Carisma Therapeutics
Carisma Therapeutics is pioneering CAR macrophage immunotherapy to target solid tumors.
-
LogicBio Therapeutics
Harnessing the body's natural DNA repair process to provide precise, stable, and durable therapies to patients with serious genetic diseases.
-
Finch
Developing and delivering innovative therapies that harness the human gut microbiome.
-
Inari
Developing and delivering innovative therapies that harness the human gut microbiome.
-
AgBiome
AgBiome develops innovative, cutting-edge solutions using new knowledge of the plant-associated microbiome to create novel products.
-
Cue Biopharma
Cue Biopharma is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system.
-
Lumen Bioscience
Lumen Bioscience makes oral antibody therapeutics.
-
EnginZyme
EnginZyme engineers cost-competitive biocatalytic solutions fast than ever before, using their universal system for enzyme immobilization.
-
Insitro
insitro will integrate cutting-edge machine learning techniques with the innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets.
-
Hibercell
HiberCell is developing first-in-class therapeutics that target dormant disseminated tumor cells from solid and liquid cancers to the prevent or delay the recurrence of cancer.
-
Rarecyte
RareCyte is enabling next-generation analysis of rare cells with an open and end-to-end platform that supports clinical trials worldwide.
-
TScan Therapeutics
TScan is harnessing novel T cell systems to extend the promise of immunotherapy.
-
Kymera Therapeutics
Kymera Therapeutics is pioneering a new therapeutic modality and platform with the potential to transform drug discovery and deliver breakthrough medicines for previously untreatable diseases.
-
GeneQuine
GeneQuine Biotherapeutics GmbH develops novel therapies for osteoarthritis, a degenerative joint disease with high unmet medical need.
-
Cedilla Therapeutics
Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics to work on diseases caused by protein dysregulation.
-
Admirx
Admirx is a preclinical-stage company developing anti-complement therapies to treat life threatening auto-immune and inflammatory diseases.
-
Cygnal Therapeutics
Cygnal Therapeutics is developing drugs to manipulate exoneural biology for the treatment of cancer, immunological diseases, and regenerative processes.
-
Quentis Therapeutics
Quentis Therapeutics is translating novel biology into new therapeutic approaches to address endoplasmic reticulum stress in multiple diseases.
-
Invaio Sciences
Invaio Sciences is a transformative early-stage startup developing a platform to control the fitness and behavior of pests and target insects in a targeted, sustainable, and natural way.
-
enEvolv
Engineering microorganisms to produce valuable bio-based products from renewable feedstocks.
-
Orum
Developing next-generation therapeutic antibodies to directly target cytosolic proteins associated with many human diseases that have been previously considered untreatable.
-
eGenesis
Making xenotransplantation a routine medical procedure for the delivery of safe & effective human transplantable cells, tissues & organs.
-
Verseau
Transforming immunotherapy.
-
Hexagon Bio
Mining massive amounts of genomic data from fungal genomes to identify novel drugs for diseases with unmet needs.
-
Pandion Therapeutics
Shifting the paradigm from systemic immunosuppression to localized immunomodulation with the next generation of targeted therapeutics.
-
Eligo Bioscience
Developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome.
-
Senti Biosciences
Leveraging expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
-
Ribometrics
Discovering small molecule drugs that target functional 3D RNA structures to treat human diseases.
